214 related articles for article (PubMed ID: 31247820)
1. Cyclometalated Gold(III) Complexes Bearing DACH Ligands.
Gukathasan S; Parkin S; Awuah SG
Inorg Chem; 2019 Jul; 58(14):9326-9340. PubMed ID: 31247820
[TBL] [Abstract][Full Text] [Related]
2. New Variations on the Theme of Gold(III) C
Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, spectroscopic characterization, electrochemical behavior and computational analysis of mixed diamine ligand gold(III) complexes: antiproliferative and in vitro cytotoxic evaluations against human cancer cell lines.
Al-Jaroudi SS; Monim-ul-Mehboob M; Altaf M; Al-Saadi AA; Wazeer MI; Altuwaijri S; Isab AA
Biometals; 2014 Dec; 27(6):1115-36. PubMed ID: 25034122
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation.
Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW
J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793
[TBL] [Abstract][Full Text] [Related]
5. Cyclometalated Complexes of Platinum and Gold with Biological Properties: State-of-the-Art and Future Perspectives.
Jurgens S; Kuhn FE; Casini A
Curr Med Chem; 2018 Feb; 25(4):437-461. PubMed ID: 28554319
[TBL] [Abstract][Full Text] [Related]
6. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
Li CK; Sun RW; Kui SC; Zhu N; Che CM
Chemistry; 2006 Jul; 12(20):5253-66. PubMed ID: 16642532
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and theoretical calculations of (1,2-diaminocyclohexane)(1,3-diaminopropane)gold(III) chloride complexes: in vitro cytotoxic evaluations against human cancer cell lines.
Al-Jaroudi SS; Altaf M; Al-Saadi AA; Kawde AN; Altuwaijri S; Ahmad S; Isab AA
Biometals; 2015 Oct; 28(5):827-44. PubMed ID: 26099502
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
9. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
[TBL] [Abstract][Full Text] [Related]
11. Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands.
Sanghvi CD; Olsen PM; Elix C; Peng SB; Wang D; Chen ZG; Shin DM; Hardcastle KI; MacBeth CE; Eichler JF
J Inorg Biochem; 2013 Nov; 128():68-76. PubMed ID: 23948576
[TBL] [Abstract][Full Text] [Related]
12. The in vitro antitumour profile of some 1,2-diaminocyclohexane organotin complexes.
Bonire JJ; Fricker SP
J Inorg Biochem; 2001 Jan; 83(2-3):217-21. PubMed ID: 11237262
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
Pages BJ; Li F; Wormell P; Ang DL; Clegg JK; Kepert CJ; Spare LK; Danchaiwijit S; Aldrich-Wright JR
Dalton Trans; 2014 Nov; 43(41):15566-75. PubMed ID: 25197979
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
15. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
[TBL] [Abstract][Full Text] [Related]
16. (C^N
Williams M; Green AI; Fernandez-Cestau J; Hughes DL; O'Connell MA; Searcey M; Bertrand B; Bochmann M
Dalton Trans; 2017 Oct; 46(39):13397-13408. PubMed ID: 28945262
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and mechanism of the reactions of Au(III) complexes with some biologically relevant molecules.
Djeković A; Petrović B; Bugarčić ZD; Puchta R; van Eldik R
Dalton Trans; 2012 Apr; 41(13):3633-41. PubMed ID: 22318647
[TBL] [Abstract][Full Text] [Related]
18. Cyclometallated Au(iii) dithiocarbamate complexes: synthesis, anticancer evaluation and mechanistic studies.
Williams MRM; Bertrand B; Hughes DL; Waller ZAE; Schmidt C; Ott I; O'Connell M; Searcey M; Bochmann M
Metallomics; 2018 Nov; 10(11):1655-1666. PubMed ID: 30255182
[TBL] [Abstract][Full Text] [Related]
19. A Conformationally Restricted Gold(III) Complex Elicits Antiproliferative Activity in Cancer Cells.
Gukathasan S; Obisesan OA; Saryazdi S; Ratliff L; Parkin S; Grossman RB; Awuah SG
Inorg Chem; 2023 Aug; 62(32):13118-13129. PubMed ID: 37530672
[TBL] [Abstract][Full Text] [Related]
20. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations.
Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M
Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
